Oxidative Medicine and Cellular Longevity / 2021 / Article / Tab 3 / Research Article
Gender-Specific Behaviour in Obesity Stages I-II: Imbalance of Aminothiol Status and Adipomyokine Profile in Subjects with Different Insulin Resistance Severity Table 3 Variables associated with male gender by logistic regression.
Univariable Multivariable OR 95% CI Adjusted OR 95% CI Plasma reduced homocysteine (μ mol/L) 0.903 0.279-2.921 0.864 Plasma total homocysteine (μ mol/L) 1.239 1.066-1.441 0.005 1.299 0.945-1.785 0.107 Plasma oxidized homocysteine (μ mol/L) 1.257 1.074-1.470 0.004 Plasma reduced cysteine (μ mol/L) 0.864 0.725-1.029 0.101 Plasma total cysteine (μ mol/L) 1.009 1.001-1.018 0.035 1.005 0.987-1.024 0.558 Plasma oxidized cysteine (μ mol/L) 1.010 1.001-1.019 0.027 Plasma reduced glutathione (μ mol/L) 0.530 0.229-1.223 0.137 Plasma total glutathione (μ mol/L) 1.421 0.916-2.204 0.117 Plasma oxidized glutathione (μ mol/L) 2.034 1.178-3.514 0.011 6.506 1.152-36.736 0.034 Leptin (ng/mL) 0.851 0.780-0.928 <0.001 0.738 0.591-0.921 0.007 Adiponectin (μ g/mL) 0.860 0.773-0.957 0.006 0.739 0.573-0.952 0.019 Myostatin (ng/mL) 0.849 0.728-0.990 0.037 0.673 0.476-0.951 0.025 Interleukin-6 (pg/mL) 0.962 0.681-1.361 0.829 Vitamin D (ng/mL) 0.929 0.870-0.993 0.029 0.897 0.780-1.031 0.125
Referent category = female. OR: odds ratio; CI: confidence interval.